Okay, let's tackle this question step by step. The question is about a 6-day-old newborn with ketonuria, seizures, and hypoglycemia. The likely diagnosis is being asked, and the correct answer is missing. The user wants a detailed explanation following their structure.

First, I need to recall the possible causes of hypoglycemia and seizures in a newborn. Ketonuria might point towards a metabolic disorder. Newborns with metabolic issues often present with hypoglycemia because their bodies can't produce enough glucose. Seizures could be due to low glucose levels affecting the brain.

Ketonuria suggests that the body is breaking down fat for energy, which happens when there's an inability to use glucose properly. This is common in disorders like fatty acid oxidation defects or glycogen storage diseases. Another possibility is congenital hypothyroidism, but that usually presents later. Galactosemia or maple syrup urine disease might also be considered, but those have other symptoms like a specific urine odor.

The most likely diagnosis here is a fatty acid oxidation disorder, such as medium-chain acyl-CoA dehydrogenase deficiency (MCAD). MCAD deficiency typically presents in infancy with hypoglycemia, ketosis, and sometimes seizures after a period of fasting or illness. The body can't convert fats into energy, leading to low glucose and ketones from fat breakdown. This fits the scenario described.

Looking at the options (though they aren't listed here), the correct answer would be MCAD deficiency. The other options might include galactosemia, maple syrup urine disease, or glycogen storage disease type I. Galactosemia usually presents with jaundice and liver issues. Maple syrup urine disease has a characteristic odor. Glycogen storage disease type I (von Gierke's disease) would cause hypoglycemia but not typically ketonuria because they can't break down glycogen, leading to fasting hypoglycemia without ketosis.

Clinical pearls: Remember that MCAD deficiency presents in early infancy with hypoglycemia and ketosis after fasting. It's important to differentiate from other metabolic disorders based on symptoms and lab findings. Newborn screening can detect some of these conditions early.

**Core Concept**
This question tests the recognition of metabolic disorders in neonates presenting with hypoglycemia, seizures, and ketonuria. The key pathophysiology involves impaired glucose production or utilization, leading to compensatory ketogenesis and neurological symptoms.

**Why the Correct Answer is Right**
The clinical scenario is classic for **medium-chain acyl-CoA dehydrogenase deficiency (MCAD)**, a fatty acid oxidation disorder. In MCAD deficiency, the body cannot metabolize medium-chain fatty acids for energy, especially during fasting. This leads to hypoglycemia (due to impaired gluconeogenesis) and ketonuria (as fat is broken down for energy). Seizures result from cerebral hypoglycemia. The 6-day-old age aligns with MCAD's typical presentation during postnatal adaptation to fasting.

**Why Each Wrong Option is Incorrect**
**Option A:** *Galactosemia* causes jaundice, hepatomegaly, and cataracts, not seizures or ketonuria.
**Option B:** *Maple syrup urine disease* presents with a distinctive sweet-smelling

✓ Correct Answer: A. Aromatic amino aciduria